 |
Adv Ther
- KANESVARAN R, Giannatempo P, Filicevas A
Empowering Patients: The Role of Shared Treatment Decision-Making in Advanced
Bladder Cancer-A Podcast.
Adv Ther. 2026 Apr 15. doi: 10.1007/s12325-026-03535.
PubMed
Abstract available
Am J Clin Pathol
- MOLNAR A, Montoya-Cerrillo D, Montgomery EA, Kryvenko ON, et al
The ancillary role of D2-40 in demonstration of muscularis propria invasion vs
desmoplastic reaction in invasive urothelial carcinoma of the bladder.
Am J Clin Pathol. 2026;165:aqag025.
PubMed
Abstract available
- GUPTA S, Kosari F, Thapa P, Murphy SJ, et al
Sarcomatoid urothelial carcinoma with constitutive PD-L1 overexpression.
Am J Clin Pathol. 2026;165:aqag023.
PubMed
Abstract available
Anal Chem
- BAO Q, Yoshioka T, Sato S, Goto S, et al
Correlation-Based Morphometric Analysis Reveals Structural Remodeling of
Platelet-Bound Circulating Tumor Cells in Urothelial Carcinoma.
Anal Chem. 2026;98:10668-10675.
PubMed
Abstract available
Ann Surg Oncol
- YANG Y, Wu Y, Yang K, Song G, et al
Preliminary Experience of Transurethral Thulium Laser En Bloc Resection of
Paraganglioma of the Urinary Bladder.
Ann Surg Oncol. 2026;33:4806-4811.
PubMed
Abstract available
- LI H, Mou Y, Liu Z, Yu C, et al
Robotic Ureteroileal Bypass Repair for Post-Cystectomy Bricker Ureteroenteric
Anastomotic Strictures: Stepwise Approach and Clinic Outcomes.
Ann Surg Oncol. 2026;33:4850-4857.
PubMed
Abstract available
- LI C, Cheng C, Li S, Wang D, et al
Integration of Node-RADS and Habitat Radiomics for Predicting Occult Nodal
Metastasis in Bladder Cancer.
Ann Surg Oncol. 2026 Apr 12. doi: 10.1245/s10434-026-19624.
PubMed
Abstract available
Appl Biochem Biotechnol
- SUN X, Qi Q, Ding X, Wang X, et al
The Tumor-Promoting Role of ADM in Bladder Cancer and its Mediated Mechanisms of
Cell Death via PKR and STAT1.
Appl Biochem Biotechnol. 2026 Apr 14. doi: 10.1007/s12010-026-05691.
PubMed
Arkh Patol
- SYCHEVA IN, Oleynikova NA
[The features of cancer-associated fibroblasts as components of tumor stroma in
bladder cancer].
Arkh Patol. 2026;88:87-93.
PubMed
Abstract available
Biochim Biophys Acta Mol Cell Res
- YAO K, Wang L, Wang J, Liu J, et al
FTO-mediated m6A demethylation inhibits bladder cancer progression via decreasing
EMG1 and reducing ribosome biosynthesis.
Biochim Biophys Acta Mol Cell Res. 2026;1873:120147.
PubMed
Abstract available
Biol Direct
- WANG Y, Gong S, Shen J, Liu G, et al
Integrative analysis of myeloid cell signatures identifies a prognostic risk
model and potential mechanisms in bladder cancer.
Biol Direct. 2026 Apr 16. doi: 10.1186/s13062-026-00785.
PubMed
Biomark Res
- ANDRZEJCZAK A, Krajewski W, Jaskula E, Chorbinska J, et al
Soluble immune checkpoints as diagnostic biomarkers in bladder cancer.
Biomark Res. 2026;14:44.
PubMed
Abstract available
Bladder Cancer
- MAI M, Tran V, Zhu A, Appiah D, et al
Patterns of care and associated social determinants of health in the definitive
treatment of localized muscle-invasive bladder cancer patients.
Bladder Cancer. 2026;12:23523735261438727.
PubMed
Abstract available
Br J Cancer
- TEKE K, Ozer C, Yaprak Bayrak B, Reyhancan IA, et al
Boron neutron capture therapy (BNCT) for experimental bladder cancer: systemic or
intravesical approach.
Br J Cancer. 2026 Apr 17. doi: 10.1038/s41416-026-03418.
PubMed
Abstract available
Cancer Cell
- MAHADEVAN KK, Kalluri R
Tumor-restraining fibroblasts emerge after chemotherapy specifically in
responders.
Cancer Cell. 2026;44:708-709.
PubMed
Abstract available
Cancer Res Commun
- ANDERSEN L, Lindskrog SV, Nordentoft I, Frydendahl A, et al
Cell-Free DNA-Derived Immune Cell Ratios Uncover Cancer-Associated Systemic
Changes.
Cancer Res Commun. 2026;6:811-820.
PubMed
Abstract available
Cancers (Basel)
- CANCERS EDITORIAL OFFICE
Expression of Concern: Juengel et al. Mechanisms Behind Temsirolimus Resistance
Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In
Vitro. Cancers 2019, 11, 777.
Cancers (Basel). 2026;18:1077.
PubMed
Abstract available
Cell Death Dis
- FAN X, Li Z, Gao Q, Huang P, et al
TRIM28 orchestrates SUMO-ubiquitin crosstalk to stabilize PPARG and drive bladder
cancer progression.
Cell Death Dis. 2026 Apr 13. doi: 10.1038/s41419-026-08745.
PubMed
Abstract available
- HUI K, Gao Y, Huang J, Xu S, et al
Correction: RASAL2, a RAS GTPase-activating protein, inhibits stemness and
epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
Cell Death Dis. 2026;17:393.
PubMed
Cell Death Discov
- NIU S, Yang P, Yao Y, Tang X, et al
NT5DC2 inhibits ferroptosis by stabilizing ACSL3 in bladder cancer.
Cell Death Discov. 2026 Apr 14. doi: 10.1038/s41420-026-03091.
PubMed
Abstract available
Clin Genitourin Cancer
- MUSAEV A, Akpinar C, Ulgen TK, Erkmen S, et al
Impact of Different Surveillance Intervals on Recurrence and Progression in
Intermediate-Risk Non-Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer. 2026;24:102543.
PubMed
Abstract available
Clin Lab
- CHA JH, Kim KJ, Yun SG, Nam MH, et al
Diagnostic Aspects of a Bacillus Calmette-Guerin (BCG) Infection Following
Intravesical Treatment for Bladder Cancer.
Clin Lab. 2026;72.
PubMed
Abstract available
Curr Urol Rep
- ANGULO-LOZANO JC, Calvillo-Ramirez A, Noyola-Perez A, Cojuc-Konigsberg G, et al
Unequal Access to Novel Systemic Therapies for Bladder Cancer: A Global Analysis
of Clinical Trials of Immune Checkpoint Inhibitors and Antibody-Drug Conjugates.
Curr Urol Rep. 2026;27:21.
PubMed
Ecotoxicol Environ Saf
- WANG J, Lu M, Qi N, Zhang M, et al
Integrated machine learning and experimental validation reveal S6K2 as a key
target of 6PPD-quinone in bladder cancer.
Ecotoxicol Environ Saf. 2026;316:120085.
PubMed
Abstract available
Front Oncol
- BAJDAK-RUSINEK K, Jankowska K, Sundararajan V, Sieron L, et al
ESRP2 constrains EMT plasticity associated with ZEB1 expression in bladder
cancer.
Front Oncol. 2026;16:1764850.
PubMed
Abstract available
Genes Genomics
- PARK C, Hwangbo H, Hong SH, Jeong HJ, et al
5-Aminoimidazole-4-carboxamide riboside, an AMPK activator, enhances
TRAIL-mediated apoptosis in human bladder cancer cells in a p38 MAPK-dependent
manner.
Genes Genomics. 2026 Apr 15. doi: 10.1007/s13258-026-01764.
PubMed
IEEE J Biomed Health Inform
- SONG Y, Yang Y, Qin J, Zhang Q, et al
Transformer-Enhanced Joint Information Extraction Framework for Bladder Cancer
Medical Dialogue Analysis.
IEEE J Biomed Health Inform. 2026;PP.
PubMed
Abstract available
Immunotherapy
- MENEGAT ALRS, Menegat BLRS, Braz LDG, Piccoli MVF, et al
Neoadjuvant immune checkpoint inhibitors for muscle-invasive urothelial
carcinoma: a systematic review and meta-analysis.
Immunotherapy. 2026;18:139-155.
PubMed
Abstract available
Int J Mol Sci
- LIPKA U, Orywal K, Gudowska-Sawczuk M
Matrix Metalloproteinases and Pro-Inflammatory Cytokines in Bladder Cancer:
Diagnostic and Prognostic Perspectives: Narrative Review.
Int J Mol Sci. 2026;27:3218.
PubMed
Abstract available
Int J Nanomedicine
- LIU Y, Chen Y, Ye S, Hu J, et al
Microwave-Responsive MnFe-Based Molybdenum Disulfide Nanoflowers for Enhanced
Thermal-Dynamic-Chemo Synergistic Therapy in Bladder Cancer.
Int J Nanomedicine. 2026;21:587614.
PubMed
Abstract available
Int J Urol
- MUTA R, Fukushima H, Tanaka H, Numao N, et al
Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After
First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter
Real-World Study (YUSHIMA Study).
Int J Urol. 2026;33:e70459.
PubMed
Abstract available
iScience
- TONG H, Li T, Zhu J, Dou Q, et al
RBM11 drives malignant progression of bladder cancer by regulating GNPDA1-PKM2
axis.
iScience. 2026;29:115402.
PubMed
Abstract available
J Cell Mol Med
- DENG H, Mi Y, Zhang L, Tan Y, et al
ARIH2 Ubiquitination Regulates NUPR1 to Inhibit Ferroptosis in Bladder Cancer.
J Cell Mol Med. 2026;30:e71147.
PubMed
Abstract available
J Clin Oncol
-
Body Size and Bladder Cancer Risk: A Pooled Analysis of Prospective Studies From
the National Cancer Institute Cohort Consortium.
J Clin Oncol. 2026 Apr 17:JCO2502155. doi: 10.1200/JCO-25-02155.
PubMed
Abstract available
J Ethnopharmacol
- HAN X, Dong S, Wang Y, Fang X, et al
Grape seed proanthocyanidin extract suppresses bladder cancer by dual blockade of
IMPDH1/2-mediated purine and pyrimidine nucleotide biosynthesis.
J Ethnopharmacol. 2026 Apr 8:121663. doi: 10.1016/j.jep.2026.121663.
PubMed
Abstract available
J Nanobiotechnology
- WEN J, Zhou B, Zhang H, Tang Y, et al
Unlocking caspase-8 enables Pt(IV) to trigger robust caspase-3/GSDME-mediated
pyroptosis via drug co-delivery in chemoresistant bladder cancer.
J Nanobiotechnology. 2026 Apr 12. doi: 10.1186/s12951-026-04449.
PubMed
Abstract available
J Transl Med
- CHEN Q, Chen T, Gan L, Lu Y, et al
Mitophagy in bladder cancer: a double-edged sword in tumor progression and
therapy.
J Transl Med. 2026;24:523.
PubMed
Abstract available
- HAN Y, Zheng Z, Li X, Fan W, et al
Letter to the editor: TGF-beta1 dominates stromal fibroblast-mediated EMT via the
FAP/VCAN axis in bladder cancer cells.
J Transl Med. 2026;24:489.
PubMed
JAMA Netw Open
- GIATSOGLOU M, Chatzistavrou D, Sopczynski JM, Feng G, et al
Clinical Outcomes in Bacillus Calmette-Guerin-Exposed Non-Muscle-Invasive Bladder
Cancer.
JAMA Netw Open. 2026;9:e267470.
PubMed
Abstract available
Medicine (Baltimore)
- HAO Y, Niu L, Shih YA, Gao P, et al
A nurse-led cross-sectional latent profile analysis of fear of cancer recurrence
in patients with non-muscle-invasive bladder cancer.
Medicine (Baltimore). 2026;105:e48370.
PubMed
Abstract available
Mod Pathol
- LI H, Argani P, Gross JM, Zhu J, et al
Loss of Methylthioadenosine Phosphorylase (MTAP) Expression: A Potentially Useful
Tool for Distinguishing Sarcomatoid Urothelial Carcinoma From Inflammatory
Myofibroblastic Tumor.
Mod Pathol. 2026;39:100980.
PubMed
Abstract available
Mol Biol Rep
- MENBARI OSKOUIE I, Khatami F, Mesbah G, Baghdadabad LZ, et al
Melatonin enhances the antitumor and immunomodulatory effects of Bacillus
Calmette-Guerin immunotherapy in a murine bladder cancer model.
Mol Biol Rep. 2026;53:600.
PubMed
Abstract available
Nat Rev Urol
- ESTEBAN-VILLARRUBIA J, de Velasco G
Targeting metastatic bladder cancer when money is an issue.
Nat Rev Urol. 2026 Apr 13. doi: 10.1038/s41585-026-01142.
PubMed
Onco Targets Ther
-
Downregulation of Long Noncoding RNA TUG1 Inhibits Proliferation and Induces
Apoptosis Through the TUG1/miR-142/ZEB2 Axis in Bladder Cancer Cells
[Retraction].
Onco Targets Ther. 2026;19:614701.
PubMed
Abstract available
Oncol Lett
- ZHU YP, Bian XJ, Ye DW, Yao XD, et al
[Expression of Concern] Pseudomonas aeruginosa-mannose-sensitive hema-gglutinin
inhibits proliferation and induces apoptosis in a caspase-dependent manner in
human bladder cancer cell lines.
Oncol Lett. 2026;31:208.
PubMed
Palliat Support Care
- PUSTAKE M, Railkar A, Ganiyani MA, Khosla AA, et al
Trends in preferred place of death among patients with bladder cancer in the
United States, 2000 to 2020.
Palliat Support Care. 2026;24:e108.
PubMed
Abstract available
Patient Prefer Adherence
- ZHANG M, Zhou Y
Bidirectional Longitudinal Associations Among Health-Related Quality of Life,
Emotional Expressivity, and Readiness to Return to Work in Patients with
Non-Muscle-Invasive Bladder Cancer Receiving Intravesical Therapy: A Three-Wave
Cohort Study.
Patient Prefer Adherence. 2026;20:594081.
PubMed
Abstract available
PLoS One
- GUO D, Li X, Xu X, Chen X, et al
The Physicochemical Synergy Effect of Nanosecond Pulsed Electric Fields (nsPEF)
and cisplatin on reversing chemoresistance of bladder cancer.
PLoS One. 2026;21:e0346699.
PubMed
Abstract available
Scand J Urol
- BJORNSSON O, Geirsson G, Leifsson AS, Nikulasson SThorn, et al
Early recurrence after primary TURBT for non-muscle-invasive bladder cancer in
Iceland: the critical role of surgical quality.
Scand J Urol. 2026;61:131-137.
PubMed
Abstract available
- MESINOVIC D, Bobjer J, Hagberg O, Aljabery F, et al
Application of the International Bladder Cancer Group prediction model for
recurrence-free survival on a national cohort of primary intermediate risk
non-muscle invasive bladder cancer.
Scand J Urol. 2026;61:127-130.
PubMed
Abstract available
Sci Adv
- ZHAO C, Hou D, Wang K, Chen J, et al
Mucoadhesive tumor-penetrating nanomedicine for intravesical chemo-immunotherapy
against bladder cancer.
Sci Adv. 2026;12:eaeb9764.
PubMed
Abstract available
Sci Rep
- WANG J, Liu H, Li K, Xie Z, et al
Therapeutic potential of asparagus polysaccharide in bladder cancer treatment via
modulation of PI3K/AKT/mTOR signaling.
Sci Rep. 2026 Apr 15. doi: 10.1038/s41598-026-47595.
PubMed
Abstract available
- WANG L, Zhang J, Liu Y, Sun Y, et al
Machine learning prediction of postoperative recurrence in bladder cancer using
clinical and laboratory indicators.
Sci Rep. 2026 Apr 15. doi: 10.1038/s41598-026-48493.
PubMed
- ZHA J, Guo X, Liao W, Wu P, et al
Inhibition of TRPC6 channel suppresses bladder cancer proliferation by disrupting
store-operated calcium entry.
Sci Rep. 2026 Apr 14. doi: 10.1038/s41598-026-45219.
PubMed
Transl Androl Urol
- OSKARSSON E, Johansson M, Liden O, Alamdari F, et al
Comorbidity alterations between time for diagnosis and radical cystectomy in
patients with muscle invasive bladder cancer undergoing neoadjuvant chemotherapy.
Transl Androl Urol. 2026;15:77.
PubMed
Abstract available
- LIU Q, Zhou P, Tian D
Identification of RNA processing-related gene-based bladder cancer subtypes for
prognosis and immune landscape assessment.
Transl Androl Urol. 2026;15:74.
PubMed
Abstract available
Transl Cancer Res
- MENG H, Wang X, Liu P, Liu Q, et al
Development and feasibility assessment of an automated, synthetic CT-guided plan
selection system for bladder cancer adaptive radiotherapy: a retrospective pilot
study.
Transl Cancer Res. 2026;15:194.
PubMed
Abstract available
Transl Oncol
- ZHU L, Liu Y, Lan J, Cai E, et al
Identification of MYC co-expression gene: POLR3G is associated with cell
senescence, immunotherapy, chemotherapy responses, and clinical prognosis in
bladder cancer patients.
Transl Oncol. 2026;68:102770.
PubMed
Abstract available
Urol Oncol
- UYSAL D, Reible B, Wildner L, Steidler A, et al
Concordance and prognostic value of antibody drug conjugate and checkpoint
inhibition targets in matched bladder cancer specimens from transurethral
resection of the bladder, radical cystectomy and lymphadenectomy.
Urol Oncol. 2026 Apr 14:111095. doi: 10.1016/j.urolonc.2026.111095.
PubMed
Abstract available
- SCILIPOTI P, Zaurito P, Longoni M, Occhi A, et al
The impact of age in patients with non-muscle-invasive bladder cancer treated
with Bacillus Calmette-Guerin.
Urol Oncol. 2026 Apr 11:111085. doi: 10.1016/j.urolonc.2026.111085.
PubMed
Abstract available
Urologia
- PACINI P, Orecchia L, Asimakopoulos AD, Manfredi M, et al
The role of Bladder EpiCheck((R)) test in predicting residual tumor after
transurethral resection of bladder cancer: Results from a pilot study.
Urologia. 2026 Apr 16:3915603261440213. doi: 10.1177/03915603261440213.
PubMed
Abstract available
World J Surg Oncol
- PENG S, Liu Y, Huang P, Liu Q, et al
MTHFD1L in muscle invasive bladder cancer: a multi-cohort study on prognosis and
therapeutic response.
World J Surg Oncol. 2026 Apr 14. doi: 10.1186/s12957-026-04346.
PubMed
Abstract available
Zhonghua Yi Xue Za Zhi
- LIANG S, Qie YK, Jia KP, Bai YD, et al
[Efficacy and safety of transvaginal assisted total intracavitary orthotopic
neobladder surgery for female urothelial carcinoma of the bladder].
Zhonghua Yi Xue Za Zhi. 2026;106:1484-1488.
PubMed
Abstract available
FAQ
